Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Oral Mucositis Pipeline Report, H2 2017 - Therapeutic Review of 11 Companies & Drug Profiles - Research and Markets

Research and Markets
Posted on: 12 Sep 17

The "Oral Mucositis - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Oral Mucositis - Pipeline Review, H2 2017 provides comprehensive information on the therapeutics under development for Oral Mucositis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Oral Mucositis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Oral Mucositis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes; the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 8, 3 and 6 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Oral Mucositis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Oral Mucositis - Overview
  3. Oral Mucositis - Therapeutics Development
  4. Pipeline Overview
  5. Pipeline by Companies
  6. Pipeline by Universities/Institutes
  7. Products under Development by Companies
  8. Products under Development by Universities/Institutes
  9. Oral Mucositis - Therapeutics Assessment
  10. Assessment by Target
  11. Assessment by Mechanism of Action
  12. Assessment by Route of Administration
  13. Assessment by Molecule Type
  14. Oral Mucositis - Companies Involved in Therapeutics Development
  • Clevexel Pharma SAS
  • Colby Pharmaceutical Company
  • Galera Therapeutics Inc
  • Humanetics Corp
  • Innovation Pharmaceuticals Inc
  • Onxeo SA
  • Oragenics Inc
  • Otsuka Holdings Co Ltd
  • Soligenix Inc
  • Spectrum Pharmaceuticals Inc
  • Spherium Biomed SL

For more information about this report visit

View source version on

Business Wire

Last updated on: 12/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.